Results 11 to 20 of about 9,985 (145)
Invasive Fungal Infections After Intestine Transplantation: Epidemiology and Outcomes [PDF]
Mycoses, Volume 69, Issue 5, May 2026.ABSTRACT Background Invasive fungal infections (IFIs) represent a major complication after intestine transplantation, with reported incidence rates between 40% and 49%. These infections are associated with high morbidity and allograft loss. This study evaluates the impact of post‐transplant IFIs on graft outcomes in intestine transplant recipients ...
Mayyadah H. Alabdely +4 more
wiley +2 more sources
Successful Management of Candida auris Bloodstream Infection in an Elderly Patient: A Case Report [PDF]
Clinical Case Reports, Volume 14, Issue 3, March 2026.ABSTRACT Candida auris is an emerging multidrug‐resistant pathogen frequently misidentified by conventional methods, posing diagnostic and infection‐control challenges, particularly in low‐ and middle‐income countries. We report a 74‐year‐old male in Dhaka, Bangladesh, with multiple comorbidities who developed Candidemia.
Arif Hasan Chowdhury +8 more
wiley +2 more sources
Micafungin Effectiveness in Treating Pediatric Patients with Proven Candidemia [PDF]
, 2022 Aim:Micafungin is one of three currently available echinocandin for the treatment of candidiasis and candidemia. We aimed to discuss the effectiveness of micafungin and any possible side effects in the treatment of proven candidemia in children.Materials
Elif Böncüoğlu +10 more
core +1 more source
ZfpA mediates micafungin tolerance.
, 2023 Susceptibility of WT CEA10, ΔzfpA, and OE::zfpA to 0.05, 0.125, 0.25, and 1 μg/mL micafungin. 104 spores were point-inoculated on solid GMM with micafungin or DMSO. Bars represent mean±s.d.
David Andes (166637) +8 more
core +1 more source
Human Tissue Distribution of Anidulafungin and Micafungin
, 2021 Concentrations of anidulafungin and micafungin were determined in eight different tissues obtained during autopsy of four deceased who had been treated with anidulafungin and of seven who had obtained micafungin.
Joannidis, Michael +5 more
core +1 more source
Micafungin-Induced Suicidal Erythrocyte Death [PDF]
, 2016 Background/Aims: The antifungal drug Micafungin is used for the treatment of diverse fungal infections including candidiasis and aspergillosis. Side effects of Micafungin treatment include microangiopathic hemolytic anemia and thrombocytopenia with ...
A. F. Mack +9 more
core +1 more source
Antiviral activity of micafungin against enterovirus 71 [PDF]
, 2016 Background: Enterovirus 71 (EV71) is a major causative agent of hand-foot-mouth disease (HFMD) and also causes severe neurological complications, leading to fatality in young children.
Sungchan Cho +16 more
core +1 more source
Breakthrough Invasive Candidiasis in Patients on Micafungin [PDF]
, 2010 For Candida species, a bimodal wild-type MIC distribution for echinocandins exists, but resistance to echinocandins is rare. We characterized isolates from patients with invasive candidiasis (IC) breaking through ≥3 doses of micafungin therapy during the
Perlin, David S. +11 more
core +1 more source
Evaluation of micafungin use in children
, 2020 Micafungin is recommended especially in patients with liver and kidney failure and in the presence of other side effects due to antifungals apart from its known priority indications such as invasive candidiasis.
Hacimustafaoglu, Mustafa
core +2 more sources
British Journal of Clinical Pharmacology, EarlyView.Aims Voriconazole is commonly used to prevent fungal infections after haematopoietic stem cell transplantation (HSCT). Although its metabolism is influenced by CYP2C19 genetics and inflammation, their combined effect is rarely considered in clinical practice, and integrated analyses remain limited.
Sylvia D. Klomp +6 more
wiley +1 more source